← Back to Search

My Anesthesia Choice for Hip Fracture

N/A

Recruiting

Led By Mark Neuman, MD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 50 and older

Planned surgery to treat a hip fracture

Must not have

Contraindication to spinal anesthesia: critical aortic stenosis

Contraindication to spinal anesthesia: skin infection over the lumbar spine

Timeline

Screening 3 weeks

Treatment Varies

Follow Up study months 12-27

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to evaluate a strategy to improve shared decision-making between doctors and patients regarding anesthesia options for hip fracture surgery at 6 US hospitals. The strategy involves using a 1-page conversation aid and

Who is the study for?

This trial is for patients with different types of hip fractures who are about to undergo surgery. The study aims to include a diverse group, but specific eligibility details aren't provided.

What is being tested?

The study tests a new approach called 'My Anesthesia Choice-HF Model' designed to improve discussions between doctors and patients about anesthesia options before hip fracture surgery at six hospitals in the US.

What are the potential side effects?

Since this intervention involves communication strategies rather than medications or medical procedures, there are no direct side effects associated with it.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 50 years old or older.

Select...

I am scheduled for surgery to fix a broken hip.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot have spinal anesthesia due to severe aortic valve narrowing.

Select...

I do not have a skin infection on my lower back.

Select...

I cannot have spinal anesthesia due to blood thinners or bleeding disorders.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ study months 12-27

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~study months 12-27

This trial's timeline: 3 weeks for screening, Varies for treatment, and study months 12-27 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Intervention reach (primary implementation outcome)

Shared Decision-Making Process scale score (SDMP; primary effectiveness outcome)

Secondary study objectives

CollaboRATE shared decision making scale score (secondary effectiveness outcome).

Other study objectives

Anesthesia type received

Decisional conflict

Fidelity of intervention delivery

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Usual CareActive Control1 Intervention

Usual care will be delivered at each site during the pre-intervention phase. Patients treated in this arm will undergo pre-anesthesia care discussions as per existing clinical routine at each site.

Group II: My Anesthesia Choice- HFActive Control1 Intervention

During the intervention and sustainment phases, site clinicians will receive standardized in-personal or virtual training on shared decision making theory and approaches. The My Anesthesia Choice-HF tool will be made available for use during preoperative conversations. Clinicians will receive encouragement to use the tool on study-eligible patients based on their assessment of clinical appropriateness.

0 / 5Eligibility criteria met